Aki Yoneda Kau

Aki Yoneda Kau is a seasoned professional in the field of molecular microbiology with extensive experience in various leadership roles. Currently serving as a Senior Consultant at Mirada Life Sciences since January 2022, Aki has previously held positions such as Director of Research and Development at resistanceBio and Chief Scientific Officer at Viosera Therapeutics. Aki's background includes a significant tenure at Washington University in St. Louis, where contributions spanned roles as a Staff Scientist and Postdoctoral Research Associate, focusing on engineering microorganisms and biochemical characterization. Aki obtained a Ph.D. in Molecular Microbiology from Washington University in St. Louis and a BS in Biological Sciences from Japan Women's University.